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Abstract
Background: Experimental and epidemiologic studies have shown that circadian clocks’ disruption can play an important role
in the development of cancer and metabolic diseases. The cellular clocks outside the brain are effectively coordinated by the body
temperature rhythm. We hypothesized that concurrent measurements of body temperature and rest-activity rhythms would assess
circadian clocks coordination in individual patients, thus enabling the integration of biological rhythms into precision medicine.
Objective: The objective was to evaluate the circadian clocks’ coordination in healthy subjects and patients through simultaneous
measurements of rest-activity and body temperature rhythms.
Methods: Noninvasive real-time measurements of rest-activity and chest temperature rhythms were recorded during the subject’s
daily life, using a dedicated new mobile electronic health platform (PiCADo). It involved a chest sensor that jointly measured
accelerations, 3D orientation, and skin surface temperature every 1-5 min and relayed them out to a mobile gateway via Bluetooth
Low Energy. The gateway tele-transmitted all stored data to a server via General Packet Radio Service every 24 hours. The
technical capabilities of PiCADo were validated in 55 healthy subjects and 12 cancer patients, whose rhythms were e-monitored
during their daily routine for 3-30 days. Spectral analyses enabled to compute rhythm parameters values, with their 90% confidence
limits, and their dynamics in each subject.
Results: All the individuals displayed a dominant circadian rhythm in activity with maxima occurring from 12:09 to 20:25.
This was not the case for the dominant temperature period, which clustered around 24 hours for 51 out of 67 subjects (76%), and
around 12 hours for 13 others (19%). Statistically significant sex- and age-related differences in circadian coordination were
identified in the noncancerous subjects, based upon the range of variations in temperature rhythm amplitudes, maxima (acrophases),
and phase relations with rest-activity. The circadian acrophase of chest temperature was located at night for the majority of people,
but it occurred at daytime for 26% (14/55) of the noncancerous people and 33% (4/12) of the cancer patients, thus supporting
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important intersubject differences in circadian coordination. Sex, age, and cancer significantly impacted the circadian coordination
of both rhythms, based on their phase relationships.
Conclusions: Complementing rest-activity with chest temperature circadian e-monitoring revealed striking intersubject differences
regarding human circadian clocks’ coordination and timing during daily routine. To further delineate the clinical importance of
such finding, the PiCADo platform is currently applied for both the assessment of health effects resulting from atypical work
schedules and the identification of the key determinants of circadian disruption in cancer patients.
(J Med Internet Res 2018;20(6):e204)   doi:10.2196/jmir.9779
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Introduction
Background
Circadian (about-24-hour) rhythms regulate mammalian
physiology, as well as cell metabolism, proliferation, and
survival over the 24 hours. These rhythms play an important
role in disease processes and treatment effects, which has been
largely overlooked in medicine [1-3]. They are generated at
single-cell level by molecular clocks, consisting of interwoven
feedback loops involving transcription-translation of 15 known
specific clock genes including Bmal1, Clock, Per2, and Rev-erbα
[4]. The molecular clocks are coordinated at the whole organism
level by the suprachiasmatic nuclei, a hypothalamic pacemaker,
which also helps circadian rhythms adjust to light-dark and
other environmental 24-hour cycles through the rhythmic control
of rest-activity, body temperature, feeding, as well as cortisol
and melatonin secretions [1-4]. Thus, both glucocorticoids and
body temperature rhythms reset molecular clocks and cellular
circadian rhythms in vitro and in vivo [5-8].
Rhythm studies in humans have assumed similar circadian
synchronization among subjects, thus inferring the reliability
of transverse sampling of different subjects at different time
points over 24 hours, and using average values for describing
circadian patterns in the group or the population [9]. Treatment
effects could also differ according to circadian timing or
chronomodulated scheduling of medications in a consistent
fashion across individual subjects with a similar circadian
entrainment [1,10-12]. Such standardized approaches to
chronotherapy proved valid in experimental rodents of same
sex, strain, and age, which were synchronized with the same
alternation of 12-hours of light and darkness, especially for
anticancer drugs [1,13]. This was also true for healthy subjects
maintained in human physiology laboratories under controlled
environmental conditions [14]. However, little is known
regarding circadian rhythms in individual healthy humans or
patients during their daily routine.
Intersubject variability in circadian phase has been suggested,
based on chronotype questionnaires administered to large
populations of presumably healthy subjects [15]. Intersubject
differences in both daily timing and 24-hour pattern have also
been shown in individual patients collecting up to 5 daily
samples of salivary cortisol and/or melatonin determinations
for up to 2 days [16-18]. The limitations resulting from such
low sampling frequency were overcome through rest-activity
monitoring, using a wrist watch accelerometer for a few days
to a few weeks [19-21]. The rest-activity time series led to
identify the dichotomy index I<O, the relative amount of activity
in bed that was below the median activity out of bed, as an
independent predictor of progression-free survival and overall
survival among 436 patients with metastatic colorectal cancer
[22]. Most importantly, the patients whose I<O was below the
median value of 97.5% had a median survival of 11.9 months,
as compared with 21.6 months for those with an I<O index over
97.5% [22]. The I<O was also negatively associated with fatigue
and appetite loss, and positively with health-related quality of
life as assessed by both the European Organization for Research
and Treatment of Cancer Quality of Life Questionnaire C30
EORTC QLQ-C30 and the MD Anderson Symptom Inventory
questionnaires in cancer patients with locally advanced or
metastatic disease [23,24]. Furthermore, circadian rest-activity
disruption, as measured with an I<O of 97.5% or less, in patients
receiving cancer chemotherapy could indeed represent an early
warning signal of deterioration and emergency hospitalization
[25,26]. However, I<O values did not correlate with sex, both
in healthy subjects or in cancer patients, or with efficacy of a
standardized chronomodulated chemotherapy protocol in cancer
patients [19,20,27], whereas the latter profoundly differed
between men and women [28]. These clinical data stressed the
need for the combination of rest-activity with circadian
temperature biomarker to gather more reliable estimates of the
circadian phase and to personalize the timing of chronotherapy.
Indeed, despite their consistent and reproducible clinical
relevance, the rest-activity time series provide imprecise
estimates regarding circadian phase, due to both its square-wave
24-hour pattern and the strong masking effect of the societal
routine on the endogenous activity rhythm. Predominant low
values of activity suggest prolonged periods of rest during
nighttime, whereas frequent high intensity activity occurs during
the day, with substantial within-day and day-to-day variability
[29]. Nevertheless, a first fixed electronic health (eHealth)
internet platform was developed within the inCASA European
project—combining telemetric activity monitoring with
self-rated symptoms and self-measured body weight. Testing
of the platform in 31 cancer patients on chronotherapy at home
demonstrated a per protocol compliance rate of ~85% over 1
month, and enabled prediction of emergency hospitalization
due to treatment toxicity 3 days in advance [26].
Precise information regarding circadian phase and circadian
coordination is also critical for the appropriate timing of
treatment delivery to reduce adverse events and/or enhance
efficacy [1,10-13,30]. Moreover, both diseases such as cancer
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and treatments can disrupt the circadian timing system (CTS)
and result in associated symptoms and reduced survival,
especially in cancer patients [31]. To address these issues, we
have designed an upper chest e-sensor that records and
teletransmits activity, temperature and tri-axial orientation. This
sensor is integrated into a novel eHealth platform (PiCADo).
The circadian rhythms in core and skin surface temperature of
men are usually 8-12 hours out of phase, with respective maxima
occurring near 16:00 at day time, and near 2:00 at night [32].
The early night drop in core body temperature results from the
vasodilatation of the skin vessels and associated rise in skin
surface temperature [33]. Such temperature changes are critical
for triggering the onset of sleep [34]. The site of temperature
measurements for achieving continuous and noninvasive, yet
reliable, assessment of human body temperature rhythms in real
life has been a challenge over the past decades. The use of a
rectal probe has been discouraged as a result of the risk of rectal
perforation [35]. Axillary and wrist skin surface temperature
records were shown to be largely contaminated by changes in
environmental temperature [36-39]. The recent availability of
an oral temperature pill has enabled the continuous recording
of internal body temperature, yet only for durations that match
the gastro-intestinal transit time, ie, ~24-48 hours [40,41].
Previous work by others highlighted the reduced influence of
environmental temperature changes on skin surface temperature
measurements taken at the upper-anterior chest wall [42,43].
We confirmed these findings through combining infrared
technology with continuous recording of patched temperature
sensors [44,45]. We further developed dedicated statistical
methods to compute dynamic changes in rhythm parameters by
combining the inference methods for obtaining interval estimates
based on spectral bootstrap with time-varying spectral estimation
[46,47].
Objectives
Here, we assessed—for the first time—the performance and
relevance of the PiCADo platform for capturing inter-and
intrasubject variabilities in the CTS both during daily routine
and in real time. We hypothesized that the combination of
rest-activity and temperature monitoring would identify large
interindividual differences in circadian coordination. The latter
would notably support the personalized adaptation of the optimal
timing of medications to jointly minimize treatment morbidities
and enhance efficacy.
Methods
Study Design
The main objective was to determine whether any inter- and
intrasubject differences in human circadian coordination could
be captured in real time through remote and noninvasive
real-time monitoring during the subjects’ usual routine. Such a
goal represented a critical step toward the personalization of
treatment timing according to individual circadian rhythms,
especially for cancer therapies. A new mobile eHealth platform
(PiCADo) was designed on purpose. The PiCADo specifications
were defined within several multidisciplinary and multiuser
focus groups involving nurses, medical oncologists, general
practitioners, biomedical and informatics engineers,
socio-anthropologists, and chronobiologists, and through
analyzing elderly people’s responses in living labs. Three
parameters—activity, temperature, and position— are measured
using a single CE-marked chest sensor emitter (Movisens,
Karlsruhe, Germany) and a pocket-sized CE-marked gateway
(Eeleo, Montrouge, France), which could gather further
information from other Bluetooth (BT)- and Bluetooth Low
Energy (BLE)-connected devices, and send them to a server via
the general packet radio service (GPRS) at the required
frequency, which may be tuned down as low as every hour, in
case of measurements of preset emergency values (Figure 1).
This latter function was not activated here. Thus, the PiCADo
platform consisted of a chest sensor that measured skin surface
temperature every 5 min, the number of accelerations, and the
orientation in 3 dimensions every min. All data were
teletransmitted via BLE to a pocket-sized gateway, which also
could gather data measured by other connected Bluetooth and
BLE devices, such as a weight scale. The gateway sent all data
to a server every 24 hours. Three cohorts of people were
involved, each with different specifications regarding
observation span (4 days vs 7-30 days), sensor-carrying method
(patch vs dedicated vest or bra), and health condition (healthy
vs cancer). Subjects in cohorts 1 and 2 had to be 21 years or
older, display no active disease, and not work at night. The study
was planned without any intervention. Subjects were advised
to remove the sensor for around 20 min once per day to avoid
contact with water during showering. The study was conducted
according to the Helsinki Declaration [48]. All the subjects
enthusiastically volunteered and provided informed consent for
carrying and testing the platform system.
Data Management
All anonymous electronic data were transferred from the
gateway at home to the server according to the GPRS
communication protocol. Once on the server, the data were
stored based on HL7 standards (international standards for
transfer of clinical and administrative data). Data were
downloaded from the server to the computer of our biomedical
engineer, who was the only person having access to the server.
Data were saved on a secure storage server according to the
national Data Protection and Freedom of Information Acts
guidance. Data transmission was inspected at least twice per
week during the monitoring sessions to insure the proper
functioning. Data were retrieved and processed at the end of
the monitoring.
Statistical Methods
Treatment of Missing Data and Data Preprocessing
Times at which subjects removed the sensor were identified
retrospectively by noting a string of zero Position and Activity
counts, jointly with corresponding temperature measurements
decreasing toward room temperature values. These intervals
were marked as missing values. To perform spectral analysis,
the raw activity and temperature data were aggregated over
hourly intervals and corresponding median values were
computed. The hourly interval length provided a good resolution
of the periodogram at frequencies of interest, especially those
corresponding to the circadian range. The endpoints of the
hourly aggregated data were connected using linear interpolation
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in case of recording gaps ≤7 hours. For gaps >7 hours, as it did
occur for 7 subjects, the recordings of the whole corresponding
24 hours were ignored for purposes of the analyses.
Estimation of Circadian Parameters
The Spectrum-Resampling (SR) algorithm [46] was applied to
estimate the circadian parameters of interest, namely, period,
amplitude, and phase of the first and second largest peaks in
the spectra for both rest-activity and temperature time series.
This method first identified the most important frequencies and
their corresponding periods from the estimated spectrum, then
fitted a Fourier-type regression model to the data, to obtain the
corresponding amplitudes and phases. The SR method provided
a bootstrap framework, where all circadian parameters were
estimated as the median of the bootstrap samples, and their 90%
central confidence intervals were approximated by the
corresponding percentiles of the bootstrap samples. To analyze
the intrasubject variability over time, the same methodology of
spectral analysis was performed over moving windows of 3
days each, with a 1-hour shift per spectral estimate [49]. We
note that the window length should be at least 2-3 days, as at
least 2 full cycles are needed to estimate the period length.
Regression Analysis
Multivariate regression analysis was applied to test for the
effects of covariates such as sex, age, weight, and cohort. As
response variable Y, we considered a selection of estimated
circadian parameters that summarized the behavior of the
biomarkers for each subject, including (1) the amplitude of the
main period of temperature, which was obtained from spectral
estimation; (2) the amplitude of activity, during prolonged
(usually daily) activity spans, as approximated by the
interquartile range (IQR) or amplitude of 50% central values
of observed values; (3) the spectral gravity center (or mean
period) of temperature; and (4) the spectral gravity center (or
mean period) of rest-activity. Possible explanatory variables
were sex, age, weight, and amplitude of daily activity as given
by the IQR of daily activity counts, cohort, and the following
interaction terms: sex*age, sex*weight, and sex*IQR of daily
activity. Model selection was performed stepwise (as
implemented in R function and based on Akaike’s information
criterion) [50]. Significance of explanatory variables was tested
by t tests of the corresponding coefficients—where a significant
effect was concluded for P values smaller than .05. As 0 and 1,
respectively, encoded for females and males, a sex-specific
effect was computed in a straightforward way in that a
sex-specific influence of a covariate was concluded, if the
coefficient corresponding to the interaction term sex*covariate
was significant in the regression.
Figure 1. eHealth domomedicine platform technology. The chest sensor embedded into the vest shirt with an open area for infrared temperature
measurements is shown in the upper left corner. The epoch length of the data points as well as length of time intervals between teletransmission events
are indicated within each circle for each variable. Teletransmissions involve Bluetooth Low Energy (BLE) from sensor to gateway and General Packet
Radio Service (GPRS) from gateway to server, from which data can be retrieved continuously.
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Results
Subject Characteristics and Study Conduct
The PiCADo Domomedicine platform was tested by 69 people.
Assessable time series of the 3 variables were obtained for 67
of 69 subjects (97%) over a median duration of 6 days (1st-3rd
quartiles, IQ, 4.0 to 12.1), ranging from 3 to 29.7 days. A total
of 30 males and 37 females, aged 21 to 83 years, participated
in 1 of 3 cohorts of subjects (Figure 2; Table 1).
All subjects were asked to keep their usual daily routines,
besides carrying the sensor day and night for the whole
monitoring duration, and keeping the gateway within a distance
of 2 m. The sensor was initially patched onto the upper left
anterior thorax of 28 healthy subjects in Cohort 1, using
Tegaderm (10x12 cm, 1626W, 3MT, Diegem, Belgium) for a
median duration of 4 days. To avoid the use of the potentially
irritating patches for longer durations, a dedicated vest and bra
were designed, which could properly lodge the sensor (Thuasne
Medical, Saint Etienne, France). This system was tested by 27
healthy subjects in 2 countries for durations ranging from 3.6
to 28.3 days (Cohort 2). The platform was used by 18 subjects
in the United Kingdom for a median duration of 7 days (Cohort
2.1), and by 9 subjects in France, jointly with a BLE weight
scale, for a median duration of 19 days (Cohort 2.2; Table 1).
To probe the platform for a prolonged use in patients with
cancer, the sensor, cloth, and gateway system was further
assessed in 12 patients with advanced or metastatic cancer for
a median duration of 18.5 days (Cohort 3, see characteristics in
Multimedia Appendix 1).
Inter- and Intrasubject Differences Captured by Time
Series Analyses
Time series were preprocessed to account for missing data (see
Material and Methods). Using the spectrum resampling method,
period, amplitude, and acrophase corresponding to the largest
(fundamental) and, if significant, second-largest peak in the
spectrum were estimated, along with their respective 90%
Confidence Limits, for each subject over the whole time span
[46]. Time-varying features of the spectrum were also estimated,
through the application of the same method to 3-day windows,
which were moved along each time series with 1-hour shifts.
The clinically relevant Dichotomy Index I<O was further
computed, over consecutive 3-day spans, with 24-hour shifts
[26,51]. Strikingly different circadian patterns, rhythm
parameters, and I<O values were identified among the 55 healthy
subjects (Figures 3 and 4). Although the rest-activity pattern
remained consistent from 1 day to the next in the 55 healthy
subjects, the temperature pattern varied from day to day in 16
of them, as revealed by changes over time in the dominant
periods and the amplitude-acrophase vectors (Figure 4, subjects
3 and 4). Thus, our methodology revealed and quantified
day-to-day changes in circadian parameters, thereby enabling
the determination of circadian variability both within and
between subjects during real-life conditions.
Figure 2. Consort diagram. The 69 subjects were enrolled in 1 of 3 cohorts that differed according to the method of sensor attachment and record
duration (first row), health status (second row), and number of subject per group, including sex, age (median and range), and record duration (median
and range).
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Table 1. Subjects and records characteristics. Median and distribution of data for all quantitative variables. M/F refers to male/female.
Missing data,
days (%)
(range) [25-
75% IQ]
Valid time se-
ries duration,
days (range)
[25-75% IQ]
# of subjects with
partial record
(cause)
BMI, kg/m2
(range) [25-
75% IQ]
Height, cm
(range) [25-
75% IQ]
Weight, kg
(range) [25-75%
IQ]
Age, years
(range) [25-
75% IQa]
Total N
(M/F)
Cohort
0 (0.8)
(0-0.3)
[0-0.1]
4.0
(3.0-4.8)
[3.9-4.0]
0——73
(44-93)
[61-77.5]
40
(25-66)
[32.7-49.5]
28
(11/17)
1
0.1 (1.5)
(0-0.6)
[0.05-0.15]
7.0
(3.6-12.4)
[7.0-7.4]
1 (charger dysfunc-
tion)
24
(19-28)
[22.2-26.1]
172
(156-183)
[168.5-175.5)]
73
(46-93)
[66.7-78]
26
(21-75)
[24-32.3]
18
(8/10)
2.1
2.3 (7.7)
(0.3-7.7)
[1.1-2.6]
19.0
(4.9-28.3)
[17.0-21.7]
3 (subject-related)b
1 (unsticking of
electronic circuit)
24
(18-31)
[23.3-26]
169
(155-195)
[162-171]
71
(54-83)
[65-72]
34
(25-57)
[27-38]
9
(4/5)
2.2
0.1 (2.0)
(0-7.7)
[0.1-1.0]
7.4
(3.6-28.3)
[7.0-15.3]
3 subject-related
2 technical failures
24.3
(17.9-31.2)
[22.3-26.2]
171
(155-195)
[165-174]
70
(46-93)
[65-77]
27
(21-75)
[24.5-37.5]
27
(12/15)
2
1.2 (5.0)
(0-20.4)
[0.7-2.7]
20.3
(4.7-29.7)
[16.5-27.2]
5 (subject-related)c22.8
(18.5-26.1)
[21.4-23.9]
170
(152-185)
[164-176]
66
(45-80)
[60-72]
61
(47-83)
[54-66.5]
12
(7/5)
3
aIQ: interquartile.
bForgetfulness after charging (N=1), travel abroad starting before end of recording span (N=1), wrong charging procedure applied (N=1).
cWrong charging procedure applied (N=2); poor tolerability of adjusted sensor-dedicated cloth due to no current use of bra (N=1), or treatment-related
itching (N=1); need for more feedback and support (N=1).
Figure 3. Inter- and intrasubject variability in circadian patterns illustrated by chronograms of rest-activity (a) and thoracic skin surface temperature
(b) of 2 healthy subjects. Panel 1 (left): time series from a 57-year-old female researcher, with usual respective times of awakening and retiring at 8:30
and 22:30; mean rest-activity I<O of 99.7%, with intrasubject coefficient of variation of 0.2%. Panel 2 (right): time series from a 27-year-old female
student, usually awakening at 8:40 and retiring at 01:00; mean I<O of 99.2%, with a coefficient of variation of 1.2%.
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Figure 4. Inter- and intrasubject variability in circadian acrophases and amplitudes of rest-activity (left panels), temperature (middle panels), and
circadian coordination (right panels). Illustrative examples through polar plots in 4 healthy subjects, whose 3-day time series shifted by 6 hours (subjects
1 and 4) or 1 hour (subjects 2 and 3), have been analyzed using the sampling-resampling spectrum analysis. The length of each vector represents the
amplitude of the dominant period and its direction points toward the timing of the corresponding acrophase.
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Figure 5. Intersubject variabilities in main rhythm parameters of healthy subjects (left columns) and cancer patients (right column). Median, interquartiles,
range, and individual values of dominant periods and corresponding amplitudes and acrophases of temperature (green) and rest-activity (blue), based
on spectral analysis of time series over the whole time span.The bottom row depicts the distribution of the dichotomy index I<O of the rest-activity
pattern in Class A or B healthy subjects, as well as in cancer patients.
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Subjects Classification According to Temperature
Periods and Circadian Coordination
Results of the spectral analyses over the complete time series
of the 28 subjects in Cohort 1 were very similar to those of the
27 subjects in Cohort 2 (see Multimedia Appendices 2 and 3).
For instance, a dominant circadian rhythm in rest-activity was
identified for all subjects, yet with a dominant circadian rhythm
in skin surface temperature for 68% (19/28) of the subjects in
Cohort 1 and 74% (20/27) of those in Cohort 2; the dominant
temperature period was about 12 hour (circa-hemidian) for 25%
(7/28) and 22% (6/27) of the subjects in Cohorts 1 and 2,
respectively. Atypical patterns were found for 2 and 1 subjects,
respectively.
Both cohorts of healthy subjects were pooled, so as to further
examine the relations between summary statistics of the
temperature and activity variables and their spectral properties,
as well as the relevance of available covariates, such as sex,
age, and weight in the 55 healthy subjects. The differences
between the acrophases of both rhythms on each tested timespan
were taken as estimates of circadian coordination.
Large intersubject differences characterized the median values
of both activity, whose median was 39.8 movements per min
[IQ, 19.3 to 54.7], and skin surface temperature, whose median
was 35.2°C [34.7 to 35.8]. The rest-activity rhythm displayed
a dominant 24-hour period for all 55 subjects. In contrast, the
skin surface temperature displayed a dominant period in the
circadian range for 39/55 subjects (71%), and in the
circahemidian range for 13/55 subjects (27%). Three out of 55
subjects (5%) displayed atypical patterns, one for both variables,
due to trans meridian travel; one with a dominant temperature
period of 6 hours; and one with an unstable temperature pattern.
We categorized the subjects as belonging to Class A (circadian
rhythms in both variables), Class B (circadian activity and
circahemidian temperature) or Class C (atypical rest-activity
and/or temperature patterns, not shown; Figure 5). For Class A,
the median circadian acrophases were located at 14:40 for
activity (with individual acrophases ranging over 7 hours 44
min, from 12:41 to 20:25), and at 3:33 at night for skin surface
temperature, yet with intersubject differences spread over 24
hours. Thus, the skin surface temperature acrophase occurred
at night (22:01 to 7:00) for 31 subjects and during day-time
(7:01 to 22:00) for 8 subjects in Class A (P<.001 from exact
Fisher test). As a result, the median time interval between both
rhythm acrophases was 11 hours 47 min, yet it had a wide range
from 7 min to 12 hours among the 39 Class A subjects.
Figure 6. Sex and sex-age dependencies of circadian amplitude (upper row) and spectrum gravity center of temperature time series (lower row) in 55
healthy subjects. (a) Box plot of temperature amplitudes of the estimated main harmonic for females (left, N=32) and males (right, N=23); (b) Sex-specific
effect of age on temperature amplitude shown by estimated regression line with 95% confidence bands. The vertical dashes along the horizontal axes
show corresponding age of each subject. (c) Box plot of the estimated gravity center of temperature spectra for females (left, N=32) and males (right,
N=23). (d) Sex-specific effect of age on the gravity center of temperature spectra shown by estimated regression line with 95% confidence bands.
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Figure 7. Inter- and intrasubject differences in circadian patterns in rest-activity and chest surface temperature as illustrated in 2 cancer patients (a and
b), with chronograms (panels 1 and 2) and polar plot representations of amplitude-acrophase vectors (panel 3).
Sex and Age Moderation of Temperature but Not
Activity Rhythms
Statistically significant pairwise Spearman correlations with
|r|≥0.4 were identified for median values and their corresponding
dominant rhythm amplitudes for both activity (r=.77) and
temperature (r=.49). Sex jointly with age had a selective
influence on the rhythmic organization of temperature, but not
that of rest-activity in the 55 healthy subjects. This was
statistically validated by multivariate regression analysis of
amplitude and spectral gravity center (or “mean period”) of
temperature, as response variables, with age and sex as
covariates (Figure 6). Females displayed larger temperature
amplitude than males (two-sample t test, P=.005; Figure 6).
Females also had larger values than males in the estimated
gravity center of their temperature spectrum (two-sample t test,
P=.03). Overall, the results indicated that females tended to
mostly display dominant 24-hour rhythm periods with large
amplitudes, whereas 12-hour rhythms tended to predominate
in males (Figure 6). The interaction between sex and both
temperature rhythm parameters was mostly apparent beyond
35 years. Regression analysis showed that sex, age, and the
interaction term sex*age had a significant effect on temperature
amplitude (with P values=.04, <.001 and .002, respectively) and
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on the gravity center of the temperature spectra (with P values
of .03, .004, and .003, respectively; Figure 6).
Circadian Coordination in Cancer Patients
A total of 7 male and 5 female patients tested the platform for
a median of 19 days, ranging from 4 to 29 days. All the patients
had previously received 1 or more chemotherapy protocols for
metastatic gastrointestinal cancer, including colorectal (N=5),
pancreatic (N=3), liver (N=2), stomach (N=1), or anal (N=1)
cancer. Moreover, 5 patients had co-morbidities (see Multimedia
Appendix 1). Six patients received chronomodulated infusions,
including 2 courses at home, while being telemonitored.
Circadian patterns in rest-activity and thoracic temperature were
identified in all the patients’ records, as shown by dominant
24-hour periods. Figure 7 depicts examples of circadian patterns
in 2 cancer patients, a 53-year-old male (patient 1) on
c o n v e n t i o n a l  c h e m o t h e r a p y  w i t h
oxaliplatin-5-fluorouracil-leucovorin delivered during
hospitalization for liver metastases from stomach cancer, on
days 1 and 2 of the recording, and a 78-year-old male (patient
2) with lung and lymph node metastases from rectal cancer,
whose treatment involved intravenous panitumumab and
chronomodulated chemotherapy with irinotecan, oxaliplatin,
5-fluorouracil, and leucovorin at home, using a 4-channel
programmable-in-time pump, from day 6 to day 9 of the
recording. Usual awaking and retiring times were 7:50 and
21:50, respectively, for patient 1 and 7:15 and 23:00,
respectively, for patient 2. Despite all patients belonging to
Class A, large interpatient variations were found regarding the
circadian amplitudes in both rest-activity (range 29.3 to 68.6
accelerations per minute) and temperature (0.17°C to 1.33°C).
Individual rest-activity acrophases varied within a 5-hour range,
occurring between 12:09 and 16:52. In contrast, the circadian
acrophases of temperature were located between 22:01 and
07:00 at night for 8 patients, and at daytime for another 4
patients. Intersubject variations were also revealed with
dichotomy index I<O, whose individual median values ranged
from 88.2% to 99.7%, with rather low estimated intrasubject
coefficients of variations of 0.3% to 6.4%. Interestingly, the
circadian acrophase of temperature was located at daytime for
3 of 6 patients with an I<O under 97.5%, but at nighttime for 5
of 6 patients, whose I<O was over 97.5% (P<.001 from exact
Fisher test).
Relations Between I<O and Chest Temperature Timing
Among the Study Population
An I<O of 97.5% or less was found in 9 of the 51 subjects, with
a 24-hour temperature rhythm (18% of Class A), and in 1 of the
13 subjects, with a 12-hour temperature pattern (8% of Class
B). We did not consider further the 3 Class C subjects (1 with
a high I<O, and 2 with a low one). Interestingly, the average
circadian acrophase of chest temperature was localized at
daytime, ie, between 7:01 and 22:00 for 6 of the 54 subjects
with a high I<O value (11%), as compared with 6 of the 10
subjects whose I<O was low (60%); P<.001 from exact Fisher
test). Indeed, having a high I<O enabled the accurate prediction
of a chest temperature occurring at night, whereas no reliable
prediction of temperature rhythm timing could be made in the
subjects whose I<O was low (see Multimedia Appendix 4).
Discussion
Effective Mobile eHealth Platform
A mobile eHealth platform (PiCADo) consisting of a BLE chest
sensor and a pocket-sized BT/BLE/GPRS gateway effectively
measured body accelerations, 3D orientation, and upper chest
temperature every 1-5 min for prolonged timespans,
teletransmitting them to a central server every 24 hours. This
interval hat can be reduced to 1 hour. In 67 healthy people or
cancer patients, this technology revealed large interindividual
differences in circadian coordination that was captured in real
time during their daily routine. The multidimensional platform
and its capabilities to combine electronic patient-reported
outcomes (PROs) with circadian rhythm monitoring and body
weight measures meet the expectations of the American Society
for Clinical Oncology, regarding the future of eHealth
technologies in cancer medicine [52]. Thus, the weekly
transmission of electronic PROs significantly improved overall
survival in 2 randomized trials conducted in cancer patients,
indicating this information might elicit initially unplanned
interventions and/or modify patient’s engagement with an
oncologic benefit equivalent to that of the addition of an active
drug [53,54]. The PiCADo platform provides a novel framework
for the further integration of circadian rhythms and other
parameters into proactive timely care interventions and the ready
assessment of their efficacy. Such technology enables a novel
systems approach for a coordinated medical and care logistics
fit for the management of chronic disease and cancer patients,
so called Domomedicine [26,55].
Technology and Compliance
The reliability and acceptance of the PiCADo platform is
illustrated from the records obtained in the subjects from 2
countries, including 55 healthy ones and 12 cancer patients at
home or during their usual activities, for prespecified durations
of 4 up to 30 days. Indeed, valid time series were extracted from
the server, and amenable to longitudinal statistical analyses.
These results are in line with those obtained previously in 31
cancer patients through a fixed internet platform within the
inCASA European project [26]. The current PiCADo platform
was developed to bypass the limitations of the inCASA platform,
through mobile technology, and multirhythm monitoring,
including skin temperature. Its specifications aimed at the broad
integration of circadian rhythms into medicine, as a potential
new information for triggering progress in the proactive
management of cancer and chronic diseases.
Further real-life tests (not shown here) indicated the reliability
of combining such rhythm telemonitoring with other physiologic
or patient-reported outcomes parameters, such as body weight
or self-rated symptoms, through additional BLE-connected
devices.
Circadian Coordination of Healthy People or Cancer
Patients During Their Daily Routine
This study has highlighted the consistency of the 24-hour
patterns in both rest-activity and thoracic skin surface
temperature from one day to the next both in healthy and
cancerous patients. However, marked intersubject differences
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were found regarding the dominant period, the spectrum central
gravity, and the amplitude and acrophase location of
temperature. More specifically, nearly 1/4 of the healthy subjects
had a prominent 12-hour rather than 24-hour periodic
temperature rhythm. Sex and age, but not weight, were
influential on the temperature rhythms, as discussed below.
Among the 39 healthy subjects with a predominantly circadian
chest temperature rhythm, the acrophase was located at night,
as expected [33,56,57], for 79% (31/39), or at daytime for 20%
(8/39). Indeed, it is known that skin surface temperature usually
increases at night, thus resulting in heat dissipation and the core
body temperature drop that has been associated to sleep
triggering [57]. In contrast, intersubject variability was limited
for rest-activity, with all the 67 subjects displaying a dominant
circadian rhythm, and 97% (65/67) of them having an acrophase
of activity located in the afternoon or early evening.
Consistently, only 5 of 55 healthy subjects had a dichotomy
index I<O between 97.5% and 95.5%, a rate in good agreement
with a prior study using wrist actigraphy in 182 young subjects
[27]. Half of the 12 cancer patients had an I<O ranging between
97.5% and 88.7%, ie, the same rate as that previously reported
using wrist actigraphy in 436 cancer patients [22,27]. This
suggests that there is consistency of both recording methods
regarding I<O estimation. There were statistically significant
relations between temperature period and amplitude on the one
hand, and sex, age, and I<O on the other hand; however, no
such correlations were found for the circadian rest-activity
parameters derived from the spectrum. Moreover, the circadian
acrophase of thoracic temperature occurred at nighttime, thus
indicating physiologic circadian coordination, for 48 of the 54
subjects (89%) whose I<O exceeded 97.5%, whereas it was
located at daytime for 6 of the 10 subjects (60%) with a lower
I<O. These findings suggest that low I<O values could reflect
nonphysiologic circadian coordination. Hence, temperature
monitoring significantly increased the information already
provided by rest-activity regarding CTS function, as suspected
in pilot studies [44,45].
Sex and Age as Important Determinants of Circadian
Coordination and Timing
Here, women aged >35 years tended to have robust 24-hour
rhythms in their temperature, with larger amplitudes as
compared with those in males. This apparent difference between
circadian rhythms in temperature and activity has a
neuroanatomic basis, which has been demonstrated in rodents
[58]. Thus, the rest-activity and temperature rhythms were
shown to be generated by the neurons located in the caudal [59]
and subparaventricular zone of the suprachiasmatic nuclei
[60,61], respectively. As body temperature is an important driver
of both the resetting and the coordination of peripheral clocks
[8], its rhythm could play a critical role for the circadian timing
of medications [13]. The larger amplitude of the circadian
rhythm in temperature shown here for women supports the
hypothesis that circadian timing of medications is even more
critical in women as compared with men. Moreover, larger
circadian amplitudes have also been found in females, compared
with males, for cortisol secretion, another key driver of
peripheral clocks and clock-controlled metabolism and cell-cycle
determinants of drug effects [5,62]. Two separate clinical trials
uncovered that the optimal timing of a multidrug
chronomodulated chemotherapy protocol could lag 6 hours
behind in women as compared with men with the same cancer
type [63,64]. Such differences in circadian amplitudes and time
lag between males and females were similar in cancer patients
and in mouse models [65,66]. The sex-related differences in
CTS that were discovered here could explain why the same
multidrug cancer chronotherapy protocol improved response
rate, progression-free survival, and overall survival in men, but
not in women with metastatic colorectal cancer, independently
of all other prognostic factors within a meta-analysis of 3
randomized international clinical trials involving 842 patients
[28].
Study Limitations and Current Perspectives
The main limitations of our study beyond the technological
possibilities of the eHealth platform was its exploratory nature,
with unbalanced sex and age distribution, as well as a limited
number of cancer patients. We did not assess chronotype via
an established questionnaire [67], or working hours, although
the temperature and activity records provided an objective and
quantitative phase assessment [68,69]. Other indicators of
circadian function, such as cortisol or melatonin rhythms or
Dim Light Melatonin Onset [70], were not determined, nor did
we investigate clock genes polymorphisms [71]. Indeed, genetic
variants of human clock genes have been shown to be associated
with phenotypic differences, which could allegedly impact
disease processes, including cancer [72]. Moreover, the various
biomarker rhythms of circadian function can be differentially
altered by disease processes [73].
Comparison With Prior Work
However, the technology supporting the platform here presented
allows to fully integrate the new information brought about by
circadian rhythms, jointly with repeated self-assessed symptoms
and other measurable parameters. The PiCADo platform
represents an answer to the limitations of the current
hospital-centered care system, which was designed for
responding to acute medical events, rather than for managing
the long-term medical care required for cancer and other chronic
diseases [74-76]. The latter illnesses not only represent the vast
bulk of health care payload in Western countries, but also their
management is suboptimal, given the current hospital logistics
constraints [77,78]. This is especially true, as disease and
treatment response dynamics vary from patient to patient, with
most events occurring at home and remaining unnoticed, while
impacting daily life, and eventually cumulating and leading to
emergency hospitalizations. In the previous inCASA study, we
showed the reliability of a fixed internet platform for the remote
monitoring of self-rated symptoms, body weight, and
rest-activity rhythm in cancer patients, and the rather good
patient compliance. Moreover, such remote monitoring provided
early warning signals of patient deterioration at home that
resulted in emergency hospitalization 3 days later. Circadian
disruption played a prominent role in the determination of such
early warning signaling [26]. Here, we aimed at improving
circadian timing disorders detection through combining
rest-activity and temperature monitoring, while being also able
to integrate self-rated symptoms and body weight measurements,
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using a mobile, rather than fixed platform. We now believe that
such PiCADo eHealth platform could shift the current
hospital-centered system of care toward a patient-centered
system promoting biomedical progress. This would involve the
safe delivery of care and support treatments at home or during
the patient’s daily activities, through adjusting cancer therapies
to circadian rhythms, ie, chronotherapy [26,79-81]. PiCAdo
further provides an ongoing monitoring system of the patient’s
well-being through developing forecasting analytical
methodology integrating multiple sources (patient-reported
outcomes, circadian rhythms in activity and temperature,
physiological measures).
Conclusions
We have shown that such a mobile eHealth circadian platform
allows automatic and noninvasive monitoring of precise
circadian parameters in nonhospitalized healthy subjects and
cancer patients. Preliminary analyses point to large and
unsuspected intersubject variabilities, which may be of great
importance when administering treatments and preventing
emergency situations. Hence, it deserves further testing as a
tool for the real-time assessment of the CTS of humans of both
sexes in various conditions, where 2 types of studies are
currently in progress or about to start, respectively, in France
and in the United Kingdom. The platform is being used for the
determination of the impact of the occupational schedule on
circadian function in the CIRCADIEM study, whereas the
service rendered by this circadian eHealth platform is to be
investigated further in cancer patients in the IDEAs study.
Clearly, such system now needs assessment over months and
in large patient cohorts within a prospective clinical trial.
eHealth circadian monitoring may indeed be of preventive and
curative interest in a number of situations involving chronic
conditions [82].
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